Funding for this research was provided by:
Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (1171113, 1171113, 1171113, 1171113)
Instituto de Salud Carlos III (PI17/01827 and PI20/00456, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN (CB12/03/30038), PI17/01827 and PI20/00456, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN (CB12/03/30038))
European Regional Development Fund (N/A, N/A)
European Cooperation in Science and Technology (CA16112, CA16112)
Balearic Islands Health Research Institute (PRIMUS, SYNERGIA, LIBERI, PRIMUS, SYNERGIA, LIBERI)
Received: 24 July 2021
Accepted: 16 December 2021
First Online: 3 February 2022
Change Date: 9 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S12889-022-12768-Y
: The application of the NEMS-CHILE instrument did not need ethical approval because no human subjects were included in data collection. However, this study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving research study participants were presented to and approved by the Ethics and Biosafety Committee of the University of Concepción, Chile, in June 2017 (ref. NEMS/2017). Informed consent was obtained from all subjects.
: The results and writing of this manuscript followed the Committee on Publication Ethics (COPE) guidelines on how to deal with potential acts of misconduct, maintaining integrity of the research and its presentation following the rules of good scientific practice, the trust in the journal, the professionalism of scientific authorship, and the entire scientific endeavor. This manuscript does not contain any individual person’s data in any form (including any individual details, images, or videos).
: None of the authors report having conflicts of interest.